시장보고서
상품코드
2104550

하지용 임플란트 시장 : 유형별, 바이오소재별, 최종사용자별, 국가별, 지역별 - 세계 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Lower Extremity Implants Market, By Type, By Biomaterial, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 358 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,672,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,556,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 8,123,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

하지용 임플란트 시장 규모는 2025년에 141억 940만 달러로 평가되며, 2026-2033년에 CAGR 3.8%로 확대할 것으로 전망되고 있습니다.

하지용 임플란트는 퇴행성 질환, 골절, 스포츠 부상으로 인해 발생한 불안정한 관절, 위치가 어긋난 뼈, 변형된 구조를 대체하는 맞춤형 정형외과용 의료기기로, 고관절, 무릎 관절, 발, 발목 임플란트에서 하중을 지탱하는 역할을 합니다. 의료기기용 바이오소재와 최신 잠금 방식을 채택한 이러한 기기는 병원, 외래 수술 센터(ASC), 그리고 정형외과 진료 현장에서 가동성 향상과 더 긴 수명에 기여하고 있습니다.

환자별로 맞춤 제작된 임플란트나 다공성 구조와 같은 혁신에 더해, 로봇 보조 수술의 도입이 급증하면서 수술의 정밀도가 향상되고 있습니다. 2025년 OECD 보고서에 따르면 고관절 및 무릎 관절 치환술은 회원국 전체에서 가장 빈번하게 시행되는 선택적 정형외과수술 중 하나로 자리 잡고 있으며, 이는 수술 수요가 지속되고 있음을 반영합니다. 평균 수명의 연장과 활동적인 고령화 사회가 진행되는 가운데, 내마모성 향상, 해부학적 설계, 그리고 최소 침습적 이식 수술에 대한 수요가 높아지고 있습니다.

하지용 임플란트 시장 - 시장 역학

퇴행성 관절 질환 및 정형외과수술 부담의 증가

퇴행성 관절염 및 노화 관련 질환, 그리고 근골격계 문제의 발생률 증가에 따라 최고의 가동성을 제공하고 장기적인 기능 장애를 완화하도록 설계된 견고한 하지 재건용 임플란트 기술에 대한 수요가 가속화되고 있습니다. 수술 후 임플란트 성능 향상과 재수술 건수 감소에 따라 임상의들 사이에서는 신소재, 첨단 베어링 표면, 강화된 고정 코팅 및 가이드 방식 무릎 임플란트를 채택한 무릎 및 고관절 임플란트에 대한 선호도가 높아지고 있습니다. 고령 환자뿐만 아니라 스포츠 부상이나 비만 등의 요인이 더해져 환자 수가 증가하고 있습니다. 또한 세계보건기구(WHO)는 2025년 근골격계 질환이 장애의 주요 원인이며, 전 세계에서 약 17억 1,000만 명에게 영향을 미치고 있다고 발표했습니다. 이 사실은 최적화된 정형외과용 임플란트의 필요성을 더욱 지원합니다. 전 세계에서 막대한 질병 부담이 존재함에 따라 임플란트 재료 및 수술 계획 시스템의 기술적 진보가 급속히 진행되고 있으며, 로봇 보조 정형외과수술의 보급도 촉진되고 있습니다.

하지 임플란트 시장 - 시장 세분화 분석:

전 세계 하지 임플란트 시장은 유형, 바이오소재, 최종사용자 및 지역에 따라 세분화되어 있습니다.

고관절 임플란트 시장은 가장 큰 부문이며, 진행성 고관절 퇴행성 관절염으로 인한 기능 저하의 진행, 고관절 대퇴골 경부 골절, 그리고 고관절 무혈성 괴사의 치료에 있으며, 고관절 치환술이 여전히 최상의 치료 선택지로 남아 있습니다. 이러한 적응증에 대응하여 고관절 임플란트 제조사들은 현재의 비구 구성품, 대퇴골 스템, 듀얼 모빌리티 임플란트 및 시멘트리스 고정법을 혁신하여 이러한 솔루션의 내구성을 높이고 임플란트 실패율을 낮추기 위해 노력하고 있습니다. 퇴행성 관절염 유병률의 증가에 따라 무릎 관절 임플란트 수술 건수는 여전히 높은 수준을 유지하고 있지만, 인식 제고, 정형외과적 재건 수술의 증가, 그리고 해부학적으로 정확한 적합성이 요구되는 스포츠 용도에 대한 관심 증대가 발·발목용 임플란트 시장의 급속한 성장을 지원하고 있습니다. 2025년, 미국 관절 치환 등록 기관(American Joint Replacement Registry)이 수집한 데이터는 고관절 및 무릎 관절 치환술에 관한 전국 규모의 데이터베이스 구축과 확충을 지속하며, 다양한 임플란트 기술에 대한 객관적이고 데이터에 기반한 비교 평가를 지원하고 있습니다.

금속계 바이오소재는 임플란트용 바이오소재의 압도적 다수를 차지하고 있습니다. 이는 하중을 지탱하는 정형외과용 임플란트에 필수적인 기계적 특성인 우수한 강도, 파괴 인성, 피로 수명, 내식성 및 내마모성을 갖추고 있기 때문입니다. 특정 표면 텍스처링이나 첨단 다공성 금속 구조를 활용한 최근 기술 혁신을 통해 임플란트와 생체 뼈 사이의 골유착이 최적화되어, 시멘트 없는 고정이 가능해졌습니다. 세라믹계 바이오소재는 마모를 최소화하는 뛰어난 베어링 표면 특성으로 인해 자주 채택되는 반면, 고도로 가교된 폴리에틸렌과 같은 폴리머계 바이오소재는 마찰을 대폭 줄여주기 때문에 관절 부위에 사용되는 경우가 있습니다. 현재 미국 식품의약국(FDA)은 다양한 혁신적인 정형외과용 바이오소재 및 관련 기술에 대해 승인을 진행하고 있으며, 이를 통해 다공성이 낮고 강도가 높으며 내구성이 뛰어난 인공 고관절 치환재의 다양화가 촉진되고 있습니다.

하지용 임플란트 시장 - 지역별 분석

전문 관절 치환 센터, 유리한 보험 환급 제도, 그리고 로봇 보조 수술의 광범위한 도입에 힘입은 성숙한 정형외과 의료 생태계 덕분에 북미는 하지용 임플란트 활용 분야에서 최첨단 위치를 차지하고 있습니다. 미국은 확립된 의료 시설 인프라와 다양한 디지털 수술 계획 시스템을 활용하는 다수의 정형외과 전문의 덕분에 시장 규모의 대부분을 차지하고 있으며, 이웃 국가인 캐나다에서는 고령화가 진행됨에 따라 선택적 정형외과 프로그램의 확대가 수요 증가를 주도하고 있습니다. 2025년 미국 정형외과학회(AAOS)가 발표한 보고서에 따르면 고관절 및 무릎 관절 치환술에 관한 근거 기반 임상 실무 지침의 수립이 지속적으로 장려되고 있으며, 북미 인공관절 시장에서는 급속한 성장과 제품 혁신이 나타나고 있습니다.

아시아태평양의 하지용 임플란트 제품 수요는 의료 산업의 현대화, 전문 정형외과 클리닉의 증가, 그리고 첨단 수술에 대한 의료 접근성 향상으로 인해 급격히 증가하고 있습니다. 외과 의사 연수에 대한 투자와 임플란트의 국내 생산을 통해 정형외과 전문 지식이 크게 향상됨에 따라 인도, 중국, 일본 등 일부 국가에서는 최소 침습 관절 치환술이 널리 채택되기 시작했습니다. 이러한 성장은 고령화의 진행과 활동적인 라이프스타일을 추구하는 고령층의 의지에 의해 더욱 가속화되고 있으며, 이러한 재건 수술을 받는 사람들이 증가하고 있습니다. 2025년까지의 향후 10년 동안, 일본 후생노동성은 국내 고령 인구(65세 이상)가 총인구의 약 30%를 차지할 것이라고 발표했으며, 이에 따라 이러한 전문적인 정형외과수술에 대한 전반적인 수요가 증가하고 있습니다.

목차

제1장 하지용 임플란트 시장 개요

제2장 개요

제3장 하지용 임플란트 주요 시장 동향

제4장 하지용 임플란트 산업 분석

제5장 하지용 임플란트 시장 : 높아지는 지정학적 긴장의 영향

제6장 하지용 임플란트 시장 구도

제7장 하지용 임플란트 시장 : 유형별

제8장 하지용 임플란트 시장 : 바이오소재별

제9장 하지용 임플란트 시장 : 최종사용자별

제10장 하지용 임플란트 시장 : 지역별

제11장 주요 벤더 분석 : 하지용 임플란트 산업

제12장 AnalystView의 전방위 전망

KSA 26.08.05

Lower Extremity Implants Market size was valued at US$ 14,109.4 Million in 2025, expanding at a CAGR of 3.8% from 2026 to 2033.

Lower extremity implants are custom-made orthopedic devices that replace destabilized joints, misplaced bones, and deformed structures caused by degenerative diseases, fractures, and sports injuries for load-bearing purposes in hip, knee, foot, and ankle implants. Implanting medical device biomaterials and modern locking methods, the devices contribute to improved mobility with longer operating lives in hospitals, ASCs, and orthopedic surgical practices.

Innovation through patient-specific and porous nature of implants, alongside the use of robotic-based procedures, has surged, improving the level of accuracy in surgery. In 2025, the OECD reported that hip and knee replacement procedures continue to rank among the most frequently performed elective orthopedic surgeries across member nations, reflecting sustained procedural demand. With increased life expectancies and an active aging population driving the need for enhanced wear properties, anatomical designs, and minimally invasive implantation procedures.

Lower Extremity Implants Market- Market Dynamics

Rising Burden of Degenerative Joint Disorders and Orthopedic Procedures

The growing incidence of osteoarthritis and age-related diseases, along with musculoskeletal problems, has accelerated the requirements for robust lower extremity reconstructed implant technologies designed to offer the best mobility and reduce long-term disability. With improving postoperative implant performance and lower revision implant surgery procedures, there has been a rising preference among clinicians for knee and hip implants loaded with new materials, advanced bearing surfaces, enhanced fixation coatings, and guided knee implants. Besides age-specific patients, other factors such as sports injuries and obesity are increasing the patient population. Moreover, in the year 2025, the World Health Organization stated that musculoskeletal conditions are a chief factor for disability, influencing nearly 1.71 billion people around the world- a fact reinforcing the need for optimized orthopedic implants. A huge global burden of disease drives rapid technological advancements in implant materials, planning surgical systems, and the growth of robotically-assisted orthopedic surgery.

Lower Extremity Implants Market- Segmentation Analysis:

The Global Lower Extremity Implants Market is segmented on the basis of Type, Biomaterial, End User, and Region.

The hip implant market largest segment where hip arthroplasty continues to be the best treatment alternative for treating the deteriorating effects of advanced osteoarthritis of the hip, the hip's femoral neck fractures, and hip's avascular necrosis. For these applications, hip implant manufacturers are innovating current acetabular components, femoral stems, dual-mobility implants, and cementless fixation so that these solutions become increasingly resilient and result in reduced rates of implant failure. Even though knee implants continue to experience large procedural volumes in response to the increasing incidence of osteoarthritis, increased awareness, reconstructive orthopedic procedures, and a greater interest in sports applications requiring anatomically precise fit have fueled rapid market growth in the foot and ankle implants market. In 2025, data collected by the American Joint Replacement Registry continued to inform and develop its nationwide database of hip and knee arthroplasty procedures, supporting objective, data-driven comparative evaluations of different implant technologies.

Metallic biomaterials account for the overwhelming majority of implant biomaterials because they offer excellent strength, fracture toughness, fatigue life, corrosion resistance, and wear properties-crucial mechanical characteristics for load-bearing orthopedic implants. Through recent innovations that leverage specific surface texturing and sophisticated porous metallic geometries, osseointegration between the implant and native bone has been optimized, allowing for non-cemented implant fixation. Ceramic-based biomaterials are frequently employed for their superior bearing surface properties, which minimize wear, while polymer biomaterials like highly cross-linked polyethylene may be preferred in articulation to significantly decrease friction. Various U.S. Food and Drug Administration (FDA) approvals are now provided for a range of innovative orthopedic biomaterials and related technologies, supporting an increased variety of less porous, stronger, and more durable hip replacements.

Lower Extremity Implants Market- Geographical Insights

A mature orthopedic care ecosystem supported by specialized joint replacement centers, favorable reimbursement structures, and widespread adoption of robotic-assisted surgery positions North America at the forefront of lower extremity implant utilization. While the United States contributes most of the volume through well-established medical facility infrastructures and an abundant number of orthopedic surgeons practicing through various digital surgical planning systems, the neighboring country Canada contributes to growing demands driven by the expanding elective orthopedic program as the aging demographic grows. According to a report published by the American Academy of Orthopaedic Surgeons (AAOS) in 2025, continuing to encourage the development of evidence-based clinical practice guidelines for hip and knee arthroplasty, the North American market for implants has witnessed rapid growth and product innovation.

The demand for lower extremity implant products in the Asia-Pacific region has experienced a dramatic surge due to modernization of the healthcare industry, growth in specialty orthopedic clinics, and increased health access for sophisticated surgeries. With significant growth in orthopedic expertise through investments in surgeon training and domestic manufacturing of implants, several countries such as India, China, and Japan have extensively started adopting minimally invasive joint replacement surgical procedures. This growth is further supported by an increasing aging demographic and their desire for active lifestyles, leading them to undergo such reconstructive surgeries. In the last decade of 2025, the Japanese Ministry of Health, Labour and Welfare announced that their country's elderly population has occupied about 30% of the entire population (aged 65+), thus raising overall demand in this specialty orthopedic surgery.

Lower Extremity Implants Market- Competitive Landscape:

Competitive positioning is based more on factors such as the lifetime of implants, integration with digitized surgery, robotic capabilities, biomaterial technology, and process optimization, rather than just a broad product range. Companies develop patient-specific implants, 3D printing, intelligent instruments, and artificial intelligence technologies, which help align implants and enhance results. The vertical integration of processes from manufacturing implants to surgical services and navigation software is one of the key competitive advantages of multinational manufacturers. In 2025, Zimmer Biomet extended the ROSA(R) robotic surgery solutions line along with their orthopedic implants due to continuous implementation programs, strengthening procedural efficiency and reinforcing technology-driven differentiation within the lower extremity implant industry.

Recent Developments:

In February 2025, Stryker launched the robotic-assisted surgical technology - expanded use of its Mako SmartRobotics applications for implant surgeries such as the hip and knee that improve surgical workflow and increase robotic accuracy.

In April 2025, Zimmer Biomet released new features on their ROSA Knee System via official product releases that enhance planning, robotic positioning, and interconnectedness between the two fields of digital imaging in an operating room.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LOWER EXTREMITY IMPLANTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • DePuy Synthes (Johnson & Johnson)
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith+Nephew plc
  • Arthrex, Inc.
  • CONMED Corporation
  • Enovis Corporation (formerly DJO Global)
  • Orthofix Medical Inc.
  • Paragon 28, Inc.
  • Acumed LLC
  • Integra LifeSciences Holdings Corporation
  • Exactech, Inc.
  • Ossur hf
  • OsteoMed
  • Others

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Hip
  • Knee
  • Foot & Ankle

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY BIOMATERIAL- MARKET ANALYSIS, 2020 - 2033

  • Ceramic Biomaterials
  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Ambulatory Surgery Centers
  • Hospitals
  • Clinics
  • Others

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Lower Extremity Implants Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lower Extremity Implants Market Snippet by Type
    • 2.1.2. Lower Extremity Implants Market Snippet by Biomaterial
    • 2.1.3. Lower Extremity Implants Market Snippet by End User
    • 2.1.4. Lower Extremity Implants Market Snippet by Country
    • 2.1.5. Lower Extremity Implants Market Snippet by Region
  • 2.2. Competitive Insights

3. Lower Extremity Implants Key Market Trends

  • 3.1. Lower Extremity Implants Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lower Extremity Implants Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lower Extremity Implants Market Opportunities
  • 3.4. Lower Extremity Implants Market Future Trends

4. Lower Extremity Implants Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lower Extremity Implants Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Lower Extremity Implants Market Landscape

  • 6.1. Lower Extremity Implants Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lower Extremity Implants Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Hip
    • 7.1.3. Knee
    • 7.1.4. Foot & Ankle

8. Lower Extremity Implants Market - By Biomaterial

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Biomaterial, 2025 & 2033 (%)
    • 8.1.2. Ceramic Biomaterials
    • 8.1.3. Metallic Biomaterials
    • 8.1.4. Polymeric Biomaterials
    • 8.1.5. Natural Biomaterials

9. Lower Extremity Implants Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Ambulatory Surgery Centers
    • 9.1.3. Hospitals
    • 9.1.4. Clinics
    • 9.1.5. Others

10. Lower Extremity Implants Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Lower Extremity Implants Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Lower Extremity Implants Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Lower Extremity Implants Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Lower Extremity Implants Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Lower Extremity Implants Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Lower Extremity Implants Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. DePuy Synthes (Johnson & Johnson)
    • 11.2.2. Stryker Corporation
    • 11.2.3. Zimmer Biomet Holdings, Inc.
    • 11.2.4. Smith+Nephew plc
    • 11.2.5. Arthrex, Inc.
    • 11.2.6. CONMED Corporation
    • 11.2.7. Enovis Corporation (formerly DJO Global)
    • 11.2.8. Orthofix Medical Inc.
    • 11.2.9. Paragon 28, Inc.
    • 11.2.10. Acumed LLC
    • 11.2.11. Integra LifeSciences Holdings Corporation
    • 11.2.12. Exactech, Inc.
    • 11.2.13. Ossur hf
    • 11.2.14. OsteoMed
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기